Schedule 13D ownership disclosure
Aviragen Therapeutics Inc
Security class unavailable · CUSIP: 053761102
Event date: 2017-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-17-000749
- Form type
- SC 13D
- Filer
- Vaxart, Inc.
- CIK
- CIK 72444
- Filed
- Nov 09, 2017
- Reporting period
- Nov 07, 2017
- Description
- Schedule 13D beneficial ownership